HealthNotablePartial
5.1
Novo Nordisk CagriSema beats Mounjaro in weight-loss trial
InfoMoney·DK · US·1 day ago
A study identified over 1 million Americans taking GLP-1 weight-loss drugs without a documented medical reason, indicating widespread off-label or non-medical use. This raises concerns about drug safety, supply strain, and healthcare costs. The finding is based on a single study and requires corroboration.